HSD11B2 and chronic kidney disease: Utilizing a cohort of patients with CKD as a human in vivo model of impaired HSD11B2 activity, we show that downstream activation of adrenal-derived 11OHA4 to 11KA4, 11KT, and 11OHT is reduced in parallel with the decline of eGFR and HSD11B2 activity.